US Patent 11040953 Process for the preparation of a diarylthiohydantoin compound
Patent 11040953 was granted and assigned to Aragon Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+169 characters)
Article
Patent abstract
Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andras Horvath0
Cyril Ben Haim0
Jennifer Albaneze-Walker0
Johan Erwin Edmond Weerts0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110409530
Date of Patent
June 22, 2021
0Patent Application Number
169399760
Date Filed
July 27, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 25 Mar, 2023
Golden AI
Infobox
Edits on 26 Sep, 2022
Golden AI
Infobox
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 11040953 Process for the preparation of a diarylthiohydantoin compound
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11040953
Date of patent
June 22, 2021
Patent application number
16939976
Date Filed
July 27, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11040953 Process for the preparation of a diarylthiohydantoin compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.